Andang, Kent .
HRN: 28-80-65 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2026
CEFOTAXIME 500MG (VIAL)
04/09/2026
04/16/2026
IV
125mg
Q12
T/late Onset Neonatal Sepsis
Checking Initial Appropriateness
04/09/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
04/09/2026
04/16/2026
IV
12.5mg
Q24
T/late Onset Neonatal Sepsis
Checking Initial Appropriateness
04/09/2026
CEFTAZIDIME 1GM (VIAL)
04/09/2026
04/16/2026
IV
85mg
Q8hours
Neonatal Sepsis
Checking Initial Appropriateness
04/13/2026
MUPIROCIN 2%, 15G (TUBE)
04/13/2026
04/19/2026
TOPICAL
-
TID
Infected Wound, Right Ear
Checking Initial Appropriateness